BioNTech launches trial of BNT326 for advanced cancers
NCT ID NCT07070232
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study tests a new drug called BNT326, given alone or with other cancer immunotherapies, in about 980 adults with advanced solid tumors that have spread or come back after prior treatment. The goal is to find the best dose and see if it is safe and effective. It is an early-stage trial, so results will help guide future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BNT326 (a drug given by IV infusion)
- What this could lead to
- If successful, this could point toward a new treatment option for people with advanced solid tumors that have stopped responding to other therapies.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with a small number of participants initially, so results may not apply broadly. Side effects are unknown and could be serious.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACRAL MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ankara Bilkent City Hospital Phase 1 Clinical Research Cente
NOT_YET_RECRUITINGAnkara, 6800, Turkey (Türkiye)
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Beatson West of Scotland Cancer Centre
RECRUITINGGlasgow, G12 0YN, United Kingdom
-
Blacktown Hospital
RECRUITINGBlacktown, New South Wales, 2148, Australia
-
Brigitte Harris Cancer Pavilion BHCP
RECRUITINGDetroit, Michigan, 48202, United States
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Centre hospitalier universitaire de Liège
RECRUITINGLiège, 4000, Belgium
-
Centro Integral Oncologico Clara Campal
RECRUITINGMadrid, 28050, Spain
-
Charité - Campus Charité Mitte
NOT_YET_RECRUITINGBerlin, 10117, Germany
-
Cleveland Clinic Taussig Cancer Center
RECRUITINGCleveland, Ohio, 44195, United States
-
Dana Farber Cancer Institute
NOT_YET_RECRUITINGBoston, Massachusetts, 02215, United States
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Traning & Research
RECRUITINGAnkara, 06200, Turkey (Türkiye)
-
Duke Cancer Institute
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRoma, 00168, Italy
-
Hacettepe Oncology Hospital
RECRUITINGAnkara, 6230, Turkey (Türkiye)
-
Hartford Healthcare
RECRUITINGHartford, Connecticut, 06102, United States
-
Hospital Beata Maria Ana
RECRUITINGMadrid, 28007, Spain
-
Hospital Clinic de Barcelona
NOT_YET_RECRUITINGBarcelona, 08036, Spain
-
Hospital Clinico San Carlos
NOT_YET_RECRUITINGMadrid, 28040, Spain
-
Hospital Universitari Vall d'Hebron - VHIO
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario Quironsalud Madrid
RECRUITINGPozuelo de Alarcón, 28223, Spain
-
Hospital de San Pedro
RECRUITINGLogroño, 26006, Spain
-
IEO Istituto Europeo di Oncologia
RECRUITINGMilan, 20141, Italy
-
Imperial College London
RECRUITINGLondon, W12 0HS, United Kingdom
-
Istituto Clinico Humanitas
RECRUITINGRozzano, 20089, Italy
-
Istituto Nazionale Tumori Fondazione G. Pascale
RECRUITINGNaples, 80131, Italy
-
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
RECRUITINGMeldola, 47014, Italy
-
Klinikum der Universität München Campus Grosshadern
NOT_YET_RECRUITINGMünchen, 81377, Germany
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
-
Mayo Clinic Arizona
NOT_YET_RECRUITINGPhoenix, Arizona, 85054, United States
-
Melanoma Institute Australia
RECRUITINGWollstonecraft, New South Wales, 2065, Australia
-
Memorial Sloan Kettering Hospital
RECRUITINGNew York, New York, 10065, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612-9497, United States
-
Northern Centre for Cancer Care
RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
-
One Clinical Research Pty Ltd
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Peninsula and South Eastern Haematology & Oncology Group
NOT_YET_RECRUITINGFrankston, Victoria, 3199, Australia
-
Queen Elizabeth Hospital
RECRUITINGBirmingham, B15 2TH, United Kingdom
-
Royal Free Hospital
RECRUITINGLondon, NW3 2QG, United Kingdom
-
Royal Marsden Hospital
RECRUITINGSutton, SM2 5PT, United Kingdom
-
Royal Marsden Hospital-London
RECRUITINGLondon, SW3 6JJ, United Kingdom
-
START Barcelona -HM Nou Delfos
RECRUITINGBarcelona, 8023, Spain
-
START Midwest, LLC
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
-
South Texas Accelerated Research Therapeutics (START), LLC
RECRUITINGSan Antonio, Texas, 78229, United States
-
Southampton General Hospital
RECRUITINGSouthampton, SO16 6YD, United Kingdom
-
St Vincent's Hospital Sydney
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
-
Tasman Oncology Research Ltd
RECRUITINGSouthport, Queensland, 4215, Australia
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The Board of Regents of the University of Wisconsin
RECRUITINGMadison, Wisconsin, 53792-6188, United States
-
The Christie Hospital
RECRUITINGManchester, M20 4BX, United Kingdom
-
The Clatterbridge Cancer Centre
RECRUITINGLiverpool, L7 8YA, United Kingdom
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Universitaetsklinikum Essen
RECRUITINGEssen, 45147, Germany
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, 9000, Belgium
-
University College London Hospitals
RECRUITINGLondon, W1T 7HA, United Kingdom
-
University of California San Francisco
NOT_YET_RECRUITINGSan Francisco, California, 94158, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Universitätsklinikum Tübingen
RECRUITINGTübingen, 72076, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
RECRUITINGMainz, 55131, Germany
-
Velindre Cancer Centre
RECRUITINGCardiff, CF14 2TL, United Kingdom
-
Yale University
RECRUITINGNew Haven, Connecticut, 06511, United States
-
Yeditepe University Kosuyolu Hospital
NOT_YET_RECRUITINGIstanbul, 34718, Turkey (Türkiye)
-
Ziekenhuis Aan de Stroom ZAS vzw
RECRUITINGWilrijk, 2610, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug cocktail shrink stomach tumors before surgery?
- Can we predict who will survive a bowel surgery leak?
- Could an AI-Designed pill take on Hard-to-Treat cancers?
- Can a new nucleotide analogue boost cancer treatment?
- Can a new Liposome-Wrapped drug shrink Hard-to-Treat solid tumors?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?